EATG » Tuberculosis

Tuberculosis

WHO issues new recommendations calling for accelerated uptake of testing and treatment for TB prevention

22 February, Geneva - The World Health Organization (WHO) recommends scaling up access to testing and treatment for TB infection, especially among groups who are particularly at risk, such as…

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 331 of the “Global Fund Observer.” The newsletter includes articles…

TB HLM Community Consultation launched

The Affected Communities and Civil Society Advisory Panel to the UN High-Level Meeting on TB (TB HLM) has launched the first phase of Community Consultations for the TB HLM to…

WHO call for patient data on the treatment of drug-resistant TB

Public call for individual patient data on treatment of multidrug- and rifampicin-resistant TB. 16 February 2018 | Geneva: In July 2018, the World Health Organization (WHO) will update its treatment…

Progress and challenges in TB vaccine development

A publication in F1000Research reviews the progress and challenges in TB vaccine development. "A new TB vaccine is... an inevitability; the question is how long will it take us to…

TB vaccine trial results offer potential for BCG revaccination, hope for subunit vaccines

Results from innovative Phase 2 tuberculosis vaccine trial offer potential for new BCG revaccination strategies, hope for subunit vaccines Study is the first 'prevention of infection' trial conducted for tuberculosis,…

Promising MSF research highlights immense benefits, need for expanded use of DR-TB drug combination

NEW YORK, FEBRUARY 14, 2018—New research published today in The Lancet Infectious Diseases journal by the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) provides strong evidence that…

Inovio and The Wistar Institute to advance vaccines against TB & malaria

Inovio and The Wistar Institute receive more than $4.6 million in R&D funding to advance vaccines against TB & malaria PLYMOUTH MEETING, Pa., Feb. 12, 2018 -- Inovio Pharmaceuticals, Inc.…

Community report: TB in Azerbaijan

Public hearing held in Azerbaijan Parliament on 30 January 2018 Public hearings were held on the 30th of January 2018 in Azerbaijan Parliament titled “Global calls and commitments – TB…

Unexpected toxicities identified with concomitant HIV, TB treatment use

Combining dolutegravir with isoniazid plus rifapentine may lead to serious side effects, including flu-like syndrome and elevated transaminase levels. The findings come from a drug-drug interaction study conducted by researchers at the…

1 2 3 36